Diabetic foot infection (incl. diabetic foot osteomyelitis)
Grade severity; probe-to-bone; debride, offload, revascularise, culture-directed abx · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Infection complicating a diabetic foot ulcer, a major cause of hospitalisation and amputation (huge burden in India/UK). Driven by neuropathy, peripheral arterial disease and hyperglycaemia. Management per IWGDF/IDSA 2023: classify severity, assess bone (osteomyelitis) and perfusion, debride, offload, and give severity- and culture-guided antibiotics with surgical source control.
Red flags
- Systemic sepsis, spreading erythema, crepitus, bullae, pain out of proportion - necrotising infection
- Wet gangrene / rapidly advancing infection - emergency surgery
- Critical limb ischaemia (absent pulses, rest pain) - urgent vascular
- Deep abscess / compartment involvement
- Severe hyperglycaemia/DKA/HHS accompanying infection
Assessment
Differential diagnosis
- Charcot neuroarthropathy (warm, swollen foot, often afebrile)
- Gout / acute crystal arthropathy
- Cellulitis without ulcer
- Critical limb ischaemia without infection
- Necrotising fasciitis / gas gangrene (limb-threatening)
Investigations
- Assess severity (IWGDF/IDSA): uninfected / mild (skin+subcut, <=2 cm erythema) / moderate (deeper or >2 cm) / severe (systemic/SIRS)
- Probe-to-bone test, measure ulcer, assess for abscess/crepitus/necrosis
- Vascular assessment: pedal pulses, ABPI/toe pressures, refer vascular if ischaemia
- Deep tissue/bone culture (NOT superficial swab) after debridement; blood cultures if systemic
- FBC, CRP/ESR, U&E, glucose/HbA1c, lactate if septic
- X-ray foot (osteomyelitis, gas, foreign body); MRI if osteomyelitis suspected and X-ray equivocal
- ESR >70 and ulcer >2 cm^2 raise osteomyelitis probability
Management
- Resuscitate sepsis; urgent surgical review for abscess, wet gangrene, necrotising infection or compartment syndrome (drainage/debridement/amputation)
- Debride non-viable tissue; obtain deep specimens for culture
- Offload pressure; optimise glycaemia; treat oedema
- Assess and restore perfusion (vascular referral/revascularisation) - antibiotics fail in ischaemic tissue
- Severity-based empirical antibiotics, then de-escalate to culture results
- Decide osteomyelitis management: surgical resection + shorter antibiotics vs antibiotics alone for selected forefoot disease
- MDT: diabetes, vascular, ortho/podiatry, ID; tetanus prophylaxis
Drugs & doses
Mild (often oral, no recent antibiotics, low MRSA risk): flucloxacillin 500 mg-1 g PO QDS OR co-amoxiclav 625 mg PO TDS, 1-2 weeks
Moderate-severe empirical: co-amoxiclav 1.2 g IV TDS OR piperacillin-tazobactam 4.5 g IV QDS (broad Gram-neg/anaerobe cover) [verify local]
Add MRSA cover (vancomycin IV, or linezolid 600 mg BD, or teicoplanin) if MRSA risk/colonisation/severe
Add anaerobic cover (metronidazole 500 mg IV/PO TDS) if gangrene/ischaemia and regimen lacks it
India/ESBL-prevalent settings: consider carbapenem (meropenem 1 g IV TDS) for severe/healthcare-associated per local antibiogram [verify local]
Osteomyelitis oral step-down (good bone penetration): clindamycin, co-trimoxazole, doxycycline, fluoroquinolone +/- rifampicin - culture-directed
Durations (IWGDF 2023): soft tissue 1-2 wks (up to 3-4 if slow); osteomyelitis ~6 wks if no resection, ~3 wks if infected bone resected, days only if all infected bone amputated
Disposition
Mild infection: discharge with oral antibiotics, podiatry/offloading and close review. Moderate/severe or osteomyelitis: admit for IV antibiotics, surgical/vascular review and MDT diabetic foot care.
Complications & pitfalls
- Osteomyelitis
- Minor/major amputation
- Sepsis and death
- Necrotising fasciitis / gas gangrene
- Recurrent ulceration, chronic non-healing wound
Exam pearls
- Superficial swabs mislead - culture deep tissue/bone after debridement
- Positive probe-to-bone in an infected ulcer strongly supports osteomyelitis
- Antibiotics cannot compensate for ischaemia or undrained pus - assess perfusion and achieve source control
- IWGDF/IDSA 2023 favours shorter, more targeted, earlier-oral regimens than older practice
- A swollen warm foot without infection may be Charcot - do not over-treat with antibiotics
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.